| 1 (139) | Hoffmann-La Roche, GmbH., Germany | DEU |  |
| 2 (143) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 3 (227) | Philips Research, Eindhoven | NLD | |
| 4 (228) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 5 (229) | Merck KGaA, Germany | DEU | |
| 6 (232) | VTT Technical Research Centre of Finland | FIN | |
| 6 (232) | AstraZeneca, United Kingdom | GBR | |
| 8 (286) | Novo Nordisk A/S | DNK | |
| 9 (301) | Siemens AG, Germany | DEU | |
| 10 (307) | Danone Nederland BV | NLD | |
| 11 (322) | Bayer AG, Germany | DEU | |
| 12 (335) | Janssen Research & Development, LLC | BEL | |
| 13 (349) | Boehringer Ingelheim GmbH Germany | DEU | |
| 14 (369) | GlaxoSmithKline, United Kingdom | GBR | |
| 15 (371) | Novartis, Switzerland | CHE | |
| 16 (397) | AstraZeneca, Sweden | SWE | |
| 17 (452) | UCB Pharma SA, Brussels | BEL | |
| 18 (458) | GlaxoSmithKline, Belgium | BEL | |
| 19 (479) | Sanofi, Germany | DEU | |
| 20 (520) | Pfizer Inc, United Kingdom | GBR | |
| 21 (537) | IMEC International | BEL | |
| 22 (539) | BASF, Germany | DEU | |
| 23 (546) | Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique | FRA | |
| 24 (583) | SINTEF Group | NOR | |
|
